Our blog features educational information and personal perspectives relevant to the hereditary cancer community.
April 05, 2022
“You are BRCA2-Positive”: Studies that Have Helped Me
Posted in...:
Research, Stories
Tags:
BRCA, Ovarian Cancer, BRCA2, Research Studies
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.
March 24, 2021
Increasing the Participation of Pregnant Women in Appropriate Clinical Research
Posted in:
Research
Tags:
Research Advocacy
March 15, 2021
Improving Memory in Menopause: the IMPRES Study
Posted in:
Research , Menopause
Tags:
Hereditary Cancer Research, Menopause, Risk-reducing Salpingo-oophorectomy
March 02, 2021
The Importance of Learning Your Pancreatic Cancer Risk When Cancer Runs in Your Family
Posted in:
Research , Genetic Testing
Tags:
BRCA, PALB2, Pancreatic Cancer, ATM, Lynch Syndrome
July 09, 2020
Advocacy Through Writing and Research
Posted in:
Research
Tags:
Hereditary Cancer, Hereditary Cancer Research, Research Advocacy, Research Studies
May 21, 2020
Clinical Trials are Essential for Improving Healthcare
Posted in:
Research , XRAY
Tags:
Hereditary Cancer, Breast Cancer, Ovarian Cancer, HBOC, Clinical Trials, Cancer Research, Research
May 20, 2020
Clinical Trials Helped Save My Life
Posted in:
Research
Tags:
Hereditary Cancer, Research, COVID19
August 27, 2018
FORCE Co-Authors Paper on Engaging Patient Advocates in Research
April 12, 2018
PARP Inhibitors and Hereditary Cancer: What’s New?
Posted in:
Research , Cancer Treatment
Tags:
BRCA, Ovarian Cancer, Genetic Testing, BRCA1, BRCA2, PALB2, Pancreatic Cancer, ATM, Gene Panel Testing, Metastatic Breast Cancer, Ovarian Cancer Treatment, PARP Inhibitor, Cancer Research, Advanced Breast Cancer, Inherited Mutations, Prostate Cancer Treatment, Metastatic Prostate Cancer, Cancer Targeted Therapy
September 19, 2017
Insurance Coverage for Clinical Trial Participation: Significant Barriers Remain
Posted in:
Laws, Protections And Public Policy , Research
Tags:
Clinical Trials, Medicare, Insurance, Insurance Coverage, Medicaid
January 31, 2017
MEDIOLA: A Clinical Trial Combining a PARP Inhibitor with an Immunotherapy Drug
Posted in:
Research
Tags:
BRCA, Breast Cancer, Ovarian Cancer, BRCA2, Ovarian Cancer Treatment
September 19, 2014
Voices of FORCE: Get Off the Sidelines and Help Win the War on HBOC
Posted in:
Research , Voices
Tags:
Patient Advocacy, Research Advocacy, Patient Centered Research, ABOUT
September 12, 2014
Voices of FORCE: A Powerful FORCE for Research
Posted in:
Research
Tags:
Patient Advocacy, Patient Engagement, Patient Centered Research, ABOUT
March 21, 2014
Matching Participants to Clinical Trials
Posted in:
Research
Tags:
Clinical Trials, Patient Engagement, Research Advocacy, ABOUT
September 06, 2013
Challenges to Hereditary Cancer Research
Posted in:
Research
Tags:
Hereditary Cancer Research, Clinical Trials, Patient Engagement, Patient Centered Research
February 11, 2013
Progress in Hereditary Cancer Treatment Research
Posted in:
Laws, Protections And Public Policy , Research
Tags:
BRCA, Breast Cancer, Ovarian Cancer, BRCA2, Young Survivor, HBOC
December 12, 2012
Clinical Trials for Hereditary Cancer: Where the Rubber Meets the Road
Posted in:
Research
Tags:
BRCA, Breast Cancer, Hereditary Cancer Research, BRCA1, BRCA2, FDA, Clinical Trials, PARP Inhibitor
December 03, 2012
Weighing the Risks and Benefits of Screening Mammography
Posted in:
Research , Risk Management
Tags:
BRCA, Breast Cancer, Hereditary Cancer Research, BRCA1, BRCA2, Previvor, Young Survivor, HBOC, USPSTF, Screening And Prevention
July 12, 2011
Prioritizing research for metastatic hereditary cancer
Posted in:
Research , Cancer Treatment
Tags:
Breast Cancer, Hereditary Cancer Research, BRCA1, Metastatic Breast Cancer
July 17, 2009
FORCE and Health Care Community Letter in Support of the EARLY Act
Posted in:
Laws, Protections And Public Policy , Research
Tags: